Clinical Trials Browser

Hepatitis, Chronic × rocakinogene sifuplasmid × 90 days × Clear all

NCT02772003 2026-03-19

DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

Phase 1 Active not recruiting

Gastrointestinal

Hepatitis, Chronic, Hepatitis C, Carcinoma, Hepatocellular